Trial NCT03639610

View at ClinicalTrials.gov 
Org. Study IDs: OP-107
Secondary IDs: 2018-000478-31

Last trial update was posted on 2023-03-10

MeSH Interventions

Dexamethasone Melphalan

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell Renal Insufficiency

Other Conditions

Renal Impairment

Stopping Reasons

The sponsor decided to terminate the study following an FDA request of a partial clinical hold.

Limitations And Caveats

Between-group comparisons were not performed in this study due the small number of patients in each cohort, as well as differences with regards to some baseline characteristics.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID